Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Canopy Growth Corporation regarding a class action lawsuit due to alleged misleading statements and undisclosed costs impacting the company's financial performance [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from May 30, 2024, to February 6, 2025 [3]. - Allegations include that Canopy Growth incurred significant costs related to the production of Claybourne pre-rolled joints and Storz & Bickel vaporizer devices, which negatively affected gross margins and overall financial results [3]. Impact on Financial Statements - The complaint claims that the defendants overstated the effectiveness of cost reduction measures and the health of gross margins while downplaying related issues, leading to materially false and misleading public statements [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by June 3, 2025, to participate in potential recovery and receive updates on the case [4]. - Registration does not require appointment as a lead plaintiff and incurs no cost or obligation [4]. Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices, seeking recovery for losses incurred due to misleading statements [5].

Financial Data and Key Metrics Changes - Net revenue for Q1 2025 reached CAD 205 million, a 3.6% increase compared to Q1 2024, driven by a combined cannabis business growth of 16.8% [12][16] - Gross profit increased by CAD 6.2 million or 12.4% year over year, resulting in a gross margin improvement to 27.6% [12][13] - Free cash flow was marginally negative at CAD -1.1 million, representing a CAD 5.3 million improvement compared to the same period in 2024 [13][15] Business Line Data and Key Metrics Changes - Liquor Retail segment recorded net revenue of CAD 109.5 million, reflecting a 5.7% decline year over year, impacted by one less day in February and Easter timing [16][17] - Cannabis Retail achieved net revenue of CAD 77.5 million, an 8.7% increase compared to the prior year, driven by a 5.2% increase in same-store sales [17][18] - Cannabis Operations segment reported net revenue of CAD 34.3 million, a 53% growth compared to the prior year, including CAD 10.2 million from the Indiva acquisition [19][20] Market Data and Key Metrics Changes - The cannabis segments continued to show strong momentum, achieving steady year-on-year revenue gains for the thirteenth consecutive quarter [4][5] - The company gained 0.3 percentage points of year-on-year market share in the cannabis retail segment [21][22] Company Strategy and Development Direction - The company is focused on three strategic pillars: growth, profitability, and people, with a commitment to expanding its cannabis retail footprint [21][25] - A formal strategic review has been initiated to evaluate the company's exposure to U.S. multistate licensed cannabis enterprises and current exchange listing status [6][9] - The acquisition of One Centimeters is expected to close by the end of Q3 2025, enhancing the company's retail presence [22] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism regarding potential excise tax reforms in Canada but does not expect material changes in the near term [46][47] - The company is not experiencing material disruptions from trade disputes, with only 5% of liquor sales coming from U.S. products [49][50] Other Important Information - The restructuring program is on track, delivering CAD 4 million in savings during Q1, corresponding to an annualized run rate of CAD 17 million [24][25] - The company is committed to investing in employee development and enhancing engagement through various initiatives [25][26] Q&A Session Summary Question: Strategy for entering the U.S. market - Management clarified that no decision has been made regarding entering the U.S. market, but existing capital exposure could facilitate entry [31][32] Question: M&A outlook for cannabis retail - Management confirmed active evaluation of both organic and inorganic growth opportunities in the Canadian retail network [35][36] Question: Rollout of loyalty program in retail - The loyalty program aims to enhance communication with consumers and provide value, with potential expansion across different product lines [40][41] Question: Insights on regulatory recommendations post-elections - Management expressed cautious optimism about regulatory reforms but does not expect significant changes in excise tax rates soon [46][47]

Core Viewpoint - LEEF Brands Inc. reported financial results for Q1 2025 and full-year 2024, highlighting a mix of growth in revenue and challenges in profitability, while emphasizing future growth potential through operational improvements and market expansion [1][4]. Financial Highlights First Quarter 2025 vs. First Quarter 2024 - Revenue increased to $9.4 million, a 19% rise from $7.9 million, driven by stronger market demand and improved sales execution [5]. - Adjusted EBITDA was -$0.8 million, down from $1.2 million, attributed to costs related to new cultivation efforts [5]. - Net income reached $2.0 million, compared to a loss of $1.8 million in the prior-year period [5]. Full Year 2024 vs. Full Year 2023 - Revenue decreased to $28.5 million, a 7% decline from $30.6 million, as the company adjusted its product and customer mix for long-term profitability [5]. - Adjusted EBITDA was -$2.4 million, compared to $1.2 million, due to investments in infrastructure and operational scalability [5]. - Net loss improved to $24.6 million, a 29% reduction from $34.7 million, aided by cost containment and operational restructuring [5]. Operational Highlights - The company appointed Jesse Redmond as Head of Investor Relations and Business Development, bringing expertise from hedge funds and cannabis analysis [6]. - Production capacity was expanded, with increases in extraction capabilities: ethanol extraction up 66%, solventless by 50%, and hydrocarbon by 38% [6]. - LEEF entered the New York market with a letter of intent to acquire a Tier 1 processing license, targeting a projected $1.5 billion market in 2025 [6]. - The company began planting at Salisbury Canyon Ranch, a significant cannabis farm, which is expected to enhance margins and product quality [6]. - Salisbury Canyon Ranch was valued at $40.8 million, significantly higher than the company's current market cap, indicating strong ROI potential [6]. Outlook - LEEF Brands anticipates improvements in revenue and gross margins throughout 2025, particularly in the latter half, driven by the first harvest at Salisbury Canyon Ranch and expansion into New York [8]. - The CEO noted a 20% year-over-year growth in unit sales during Q1, reflecting strong demand and positioning for a transformational year ahead [9].

Core Viewpoint - Christina Lake Cannabis Corp. has successfully closed the first tranche of a non-brokered private placement, raising a total of CDN $1,138,910.55 through the issuance of units, which consist of common shares and warrants [1][2]. Group 1: Offering Details - The first tranche involved the issuance of 22,778,211 units at a price of $0.05 per unit, primarily as a debt settlement for existing convertible debenture holders [2]. - The offering is pending regulatory approval, including acceptance from the Canadian Securities Exchange (CSE), and all securities issued will be subject to a hold period of four months and one day [3]. - The company anticipates completing additional closings by May 30, 2025 [3]. Group 2: Related Party Transactions - Certain directors and officers subscribed for a total of 21,524,011 units, generating gross proceeds of $1,076,200.55, which qualifies as a related party transaction [4]. - The company plans to rely on exemptions from minority shareholder approval and formal valuation requirements due to the transaction's value not exceeding $2,500,000 [4]. Group 3: Company Overview - Christina Lake Cannabis is a licensed cannabis producer in Canada, with facilities covering 32 acres and over 950,000 square feet of outdoor grow space, focusing on high-quality extracts and distillates for B2B clients [6].

Core Viewpoint - Rubicon Organics Inc. has increased its non-brokered private placement offering from $3 million to $4.5 million due to strong market demand, aiming to raise funds for growth initiatives and capital investments [1][6]. Group 1: Offering Details - The offering will consist of up to 10,227,272 units priced at $0.44 per unit, with potential gross proceeds of up to $4.5 million [1]. - Each warrant allows the holder to acquire one common share at $0.70 for 24 months, with an accelerated expiry option if the share price exceeds $1.00 for 20 consecutive trading days [1]. - The offering is made under the listed issuer financing exemption and will not be subject to a hold period under Canadian securities laws [2]. Group 2: Use of Proceeds - Net proceeds from the offering will be allocated for the start-up and acquisition costs of the Hope Facility, pre-roll automation, capital investments, and general working capital [5]. - If the acquisition of the Hope Facility does not occur, proceeds may be redirected to other projects or future facility acquisitions [5]. Group 3: Company Overview - Rubicon Organics is a licensed producer focused on organic certified and premium cannabis products, with a vertically integrated business model [9]. - The company aims for industry-leading profitability through its premium cannabis flower and brand portfolio, which includes flagship brands such as Simply Bare™ Organic and 1964 Supply Co™ [9][10].

Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that negatively impacted investors between May 30, 2024, and February 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Canopy Growth Corporation made false statements regarding the costs associated with the production of Claybourne pre-rolled joints and Storz & Bickel vaporizer devices, which were likely to adversely affect the company's gross margins and overall financial results [2]. - It is alleged that the defendants overstated the effectiveness of Canopy's cost reduction measures and the health of its gross margins while downplaying related issues, leading to materially false and misleading public statements [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Company Overview - Glass House Brands Inc. is one of the fastest-growing, vertically integrated cannabis companies in the U.S. with a focus on the California market [3] - The company is dedicated to building leading brands and serving consumers across all segments, with a commitment to sustainability and community respect [3] Financial Reporting - Glass House will report its financial results for the first quarter of 2025, which ended on March 31, 2025, on May 13, 2025, after market close [1] - A conference call to discuss the results will be held at 5:00 p.m. Eastern Time on the same day [1] Communication and Accessibility - Participants can access the live webcast of the conference call on the Glass House Brands website, which will be archived for approximately 30 days [2] - For those interested in dialing in, a specific conference ID is provided for access [2]

Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that affected investors between May 30, 2024, and February 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Canopy Growth Corporation made false statements regarding the costs associated with the launch of Claybourne pre-rolled joints and the Storz & Bickel vaporizer devices, which negatively impacted the company's gross margins and financial results [2]. - It is alleged that the company overstated the effectiveness of its cost reduction measures and misrepresented the health of its gross margins while downplaying related issues [2]. Group 2: Investor Participation - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Group 1 - Cronos Group Inc. will hold its 2025 Annual Meeting of Shareholders on June 20, 2025, at 11:00 a.m. ET [1] - The meeting will be conducted in a virtual-only format, allowing registered shareholders and proxyholders to participate online [2] - Detailed instructions for participation and the formal business to be conducted at the meeting are available in the Company's proxy statement on its website [3] Group 2 - Access information for the meeting includes a live audio webcast link and a replay available 24 hours after the meeting [4] - Cronos is a global cannabinoid company focused on cannabis research, technology, and product development, with brands like Spinach®, PEACE NATURALS®, and Lord Jones® [5]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Canopy Growth Corporation regarding a class action lawsuit due to alleged misleading statements and undisclosed costs impacting the company's financial performance [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from May 30, 2024, to February 6, 2025 [3]. - Allegations include that Canopy Growth incurred significant costs related to the production of Claybourne pre-rolled joints and Storz & Bickel vaporizer devices, which negatively affected gross margins and overall financial results [3]. Impact on Financial Statements - The complaint claims that the defendants overstated the effectiveness of cost reduction measures and the health of gross margins while downplaying related issues, leading to materially false and misleading public statements [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by June 3, 2025, to monitor the case's progress and potentially seek lead plaintiff status [4]. - Registration is free and does not obligate shareholders to participate in the case [4]. Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [5].